Skip to content
TARS Tarsus Pharmaceuticals, Inc. Common Stock
$0.00 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy TARS stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 1.8B
Enterprise value 1.5B
Trailing PE -10.069264168347
Forward PE -21.564816
PEG Ratio -21.564816
Enterprise to EBITDA -11.004
Enterprise to revenue 11.839
Price to book MRQ 7.49236
Price to sales TTM 13.737041

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter (MRQ) 2024-09-30
Revenue (TTM) 129.6M
EBITDA -139458000
Diluted EPS TTM -3.75
Total Cash (MRQ) 317M
Current ratio (MRQ) 5.422
Operating Cash Flow (TTM) -100180000

TARS trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent TARS News

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account?

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.